Skip to main content
. 2020 Jul 28;123(8):1271–1279. doi: 10.1038/s41416-020-1002-8

Fig. 4. Consort diagram of the distribution of patients within the curative patient cohort with ctDNA-positive/negative blood samples.

Fig. 4

Includes reference to timelines for curative patients shown in Supplementary Fig. 14.